758
Participants
Start Date
December 8, 2020
Primary Completion Date
June 5, 2025
Study Completion Date
March 30, 2027
Cobolimab
Cobolimab will be administered.
Dostarlimab
Dostarlimab will be administered.
Docetaxel
Docetaxel will be administered.
GSK Investigational Site, Adana
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
GSK Investigational Site, Florida
GSK Investigational Site, Melbourne
GSK Investigational Site, Ballarat
GSK Investigational Site, Mount Waverley
GSK Investigational Site, Hasselt
GSK Investigational Site, South Brisbane
GSK Investigational Site, Ashford
GSK Investigational Site, Hobart
GSK Investigational Site, Kortrijk
GSK Investigational Site, Aalst
GSK Investigational Site, New York
GSK Investigational Site, Orbassano to
GSK Investigational Site, Dusit
GSK Investigational Site, Gyeonggi-do
GSK Investigational Site, White Plains
GSK Investigational Site, Taipei
GSK Investigational Site, Mineola
GSK Investigational Site, Athens
GSK Investigational Site, Athens
GSK Investigational Site, Pathum Thani
GSK Investigational Site, Berlin
GSK Investigational Site, Athens
GSK Investigational Site, Marseille
GSK Investigational Site, Seongnam-si Gyeonggi-do
GSK Investigational Site, A Coruña
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Monza
GSK Investigational Site, Fredericksburg
GSK Investigational Site, Oldenburg
GSK Investigational Site, Rio Patras
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Cheongju Chungcheongbuk-do
GSK Investigational Site, Málaga
GSK Investigational Site, Quimper
GSK Investigational Site, Las Palmas de Gran Canar
GSK Investigational Site, Rennes
GSK Investigational Site, Izmir
GSK Investigational Site, Tours
GSK Investigational Site, Grenoble
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Edgewood
GSK Investigational Site, Larissa
GSK Investigational Site, Daegu
GSK Investigational Site, Guadalajara
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Pusan
GSK Investigational Site, Florence
GSK Investigational Site, Cologne
GSK Investigational Site, Iowa City
GSK Investigational Site, Siena
GSK Investigational Site, Bonn
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Sioux Falls
GSK Investigational Site, Ancona
GSK Investigational Site, Frankfurt
GSK Investigational Site, Frankfurt
GSK Investigational Site, Monterrey
GSK Investigational Site, Heidelberg
GSK Investigational Site, Kuopio
GSK Investigational Site, Puebla Puebla
GSK Investigational Site, Karlsruhe
GSK Investigational Site, Houston
GSK Investigational Site, Napoli
GSK Investigational Site, München
GSK Investigational Site, München
GSK Investigational Site, Avellino
GSK Investigational Site, Augsburg
GSK Investigational Site, Las Vegas
GSK Investigational Site, Kho Hong Hat Yai
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Créteil
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Honolulu
GSK Investigational Site, Tacoma
GSK Investigational Site, Bad Berka
GSK Investigational Site, Córdoba
GSK Investigational Site, Moscow Region
GSK Investigational Site, Pushkin
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Craiova
GSK Investigational Site, Craiova Dolj
GSK Investigational Site, Timișoara
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Blumenau
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Norwich
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Cipoletti Rio Negro
GSK Investigational Site, La Rioja
GSK Investigational Site, Pergamino
GSK Investigational Site, Rosario
GSK Investigational Site, Viedma
GSK Investigational Site, Fortaleza
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Salvador
GSK Investigational Site, São Paulo
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Kingston
GSK Investigational Site, Oshawa
GSK Investigational Site, Greenfield Park
GSK Investigational Site, Montreal
GSK Investigational Site, Helsinki
GSK Investigational Site, Nice
GSK Investigational Site, Dresden
GSK Investigational Site, Halle
GSK Investigational Site, Athens
GSK Investigational Site, Pylaia Thessaloniki
GSK Investigational Site, Perugia
GSK Investigational Site, Kyoto
GSK Investigational Site, Miyagi
GSK Investigational Site, Osaka
GSK Investigational Site, Yamaguchi
GSK Investigational Site, Mexico City
GSK Investigational Site, Mexico City
GSK Investigational Site, Mexico City
GSK Investigational Site, Mexico City
GSK Investigational Site, Amersfoort
GSK Investigational Site, Enschede
GSK Investigational Site, Groningen
GSK Investigational Site, Harderwijk
GSK Investigational Site, Nijmegen
GSK Investigational Site, Utrecht
GSK Investigational Site, Zwolle
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Gdynia
GSK Investigational Site, Lodz
GSK Investigational Site, Olsztyn
GSK Investigational Site, Piła
GSK Investigational Site, Poznan
GSK Investigational Site, Bucharest
GSK Investigational Site, Otopeni
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon Kyunggi-do
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Burgos
GSK Investigational Site, Gävle
GSK Investigational Site, Stockholm
GSK Investigational Site, Uppsala
GSK Investigational Site, Antalya
GSK Investigational Site, Cardiff
GSK Investigational Site, Edinburgh
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Manchester
Lead Sponsor
GlaxoSmithKline
INDUSTRY